Monday, March 30, 2020

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.

from Moneycontrol Business News https://ift.tt/3artekw

No comments:

Post a Comment

Equitas Small Finance Bank chief PN Vasudevan plans exit over perceived conflict involving daughter's NBFC

PN Vasudevan's recent announcement of his resignation as managing director of Equitas Small Finance Bank highlights pressing concerns ov...